Stevanato Group (NYSE:STVN – Get Free Report) and Standard BioTools (NASDAQ:LAB – Get Free Report) are both healthcare companies, but which is the superior stock? Get Stevanato Group alerts:Risk & VolatilityStevanato Group has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Analyst RecommendationsThis is a breakdown of current recommendations and price targets for Stevanato Group and Standard BioTools, as reported by MarketBeat. Given Standard BioTools’ higher possible upside, analysts plainly believe Standard BioTools is more favorable than Stevanato Group. Net Margins Return on Equity Return on Assets Stevanato Group 10.99% 10.43% 6.16% Standard BioTools 100.36% -7.57% -6.14%SummaryStevanato Group beats Standard BioTools on 10 of the 15 factors compared between the two stocks.